Article Details

Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights

Retrieved on: 2021-08-10 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights. View article details on hiswai:

Excerpt

(NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up